US EditionPublished • loading... • Updated
Spherix Global Insights Reveals Unmet Need Driving Interest in Emerging Therapies for Thyroid Eye Disease
Summary by The Hamilton Spectator
4 Articles
4 Articles
WellandTribune.ca+3 Reposted by 3 other sources
Spherix Global Insights Reveals Unmet Need Driving Interest in Emerging Therapies for Thyroid Eye Disease
Exton, PA, Nov. 12, 2025 (GLOBE NEWSWIRE) -- New research from Spherix Global Insights finds that while Amgen’s Tepezza (teprotumumab) continues to anchor the treatment landscape for thyroid eye disease (TED), physicians emphasize ongoing unmet needs—particularly for patients with milder…
Coverage Details
Total News Sources4
Leaning Left4Leaning Right0Center0Last UpdatedBias Distribution100% Left
Bias Distribution
- 100% of the sources lean Left
100% Left
L 100%
Factuality
To view factuality data please Upgrade to Premium
